Objective: Recent epidemiological studies indicated that baseline C-reactive protein (CRP) levels may have value in prediction of cardiovascular risk.
INTRODUCTION
Recent epidemiological studies demonstrated that plasma C-reactive protein (CRP) levels were associated with ischemic cardiovascular/cerebrovascular disease among apparently healthy individuals (3, 9, 11, 19, 27) . CRP is primarily synthesized and secreted into circulation from the liver. The level of CRP in circulation can increase rapidly and dramatically in response to cytokines, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNFa) (25) . This response occurs at the transcriptional level.
CRP levels demonstrate substantial inter-individual variability. Family studies demonstrated that CRP levels are substantially determined by heritable factors (~30-50%) (2, 10, 20, 24, 26, 40) . The combination of sociodemographic factors, behavioral and lifestyle factors, obesity and fat patterning, and prevalent diabetes explained 13-30% the interindividual variability of these traits (24) . Although several genetic polymorphisms in the CRP gene have been documented to be associated with CRP levels (5, 7, 12, 18, 28, 34, 35, 41) , it is still controversial if these local genetic polymorphisms on the CRP gene are associated with cardiovascular traits (8, 17, 41) .
The 5' and 3'-flanking regions usually make significant contributions to the control of the quantitative amount of gene expression. In fact, it has been demonstrated by a transgenic mouse model that both 5' and 3'-flanking regions are involved in the regulation of CRP gene expression (38) . In this study, we systematically screened the 5' and 3'-flanking regions of the CRP gene for novel genetic polymorphisms and investigated their associations with plasma CRP levels and cardiovascular risk in the NHLBI Family Heart Study (FHS) population.
Genetic studies can provide insight into causation because they are less inclined to be affected by confounding and reverse causation. CRP genotypes precede physiological and pathological states, such as a low-grade chronic inflammatory condition; therefore, the investigation of direct association of CRP genotypes with cardiovascular traits may help to elucidate the role of the CRP elevation in development of cardiovascular disease.
METHODS

Study Population
The NHLBI Family Heart Study (FHS) selected probands from 4 population-based cohorts, the Atherosclerosis Risk in Communities Study (Forsyth County, NC and suburban Minneapolis, MN centers), the Utah Health Family Tree Study (Salt Lake City, Utah), and the Framingham Heart Study (Framingham, MA). A total of 5381 subjects from 1245 two-to threegeneration families (657 high coronary heart disease [CHD] risk and 588 random) completed an extensive clinical examination in 1994-95. A complete description of this study can be found in Higgins, et al. (15) . For the present study, analysis was limited to Caucasian subjects who had CRP levels and other covariates measured (N=1296), as described elsewhere (24) . The AfricanAmerican subjects did not have CRP measured at the time of this study. Serum CRP was measured at the Laboratory for Clinical Biochemistry Research, University of Vermont by a sensitive enzyme-linked immunosorbent assay method calibrated with World Health Organization reference material (13, 24) . The intra-and inter-assay CVs were 3% and 6%, respectively. Alcohol consumption and smoking status were coded as current or not. Prevalent CHD (N=174) was defined as medical record validation of reported history of myocardial infarction, coronary bypass surgery or percutaneous transluminal coronary angioplasty. Intima media thickness (IMT) was measured by ultrasound at the common carotid, internal carotid, and at the bifurcation (13) . The mean wall thickness in the 1-cm segment of the right and left common carotid artery proximal to the dilatation of the carotid bulb were estimated. Table 1 shows the baseline characteristics of the study population. The study was approved by an institutional review committee at each site and the subjects gave informed consent.
Experimental Approach of Novel SNP (Single Nucleotide Polymorphism) Discovery
This project was focused on the 5' and 3' flanking regions, which is complementary to the target regions of the SeattleSNP project with a ~1000 bp overlap (Fig.1) . A systematic search for novel genetic variants in the CRP gene was performed by denaturing high performance liquid chromatography (DHPLC) on the WAVE System (Transge nomic). DNA samples from Coriell Repositories (African-American AA-100 Panel and European-American Cau-100 Panel, N=46 unrelated subjects for each) were used. Polymerase chain reaction (PCR) primers for overlapping amplicons were designed to cover the entire targeted regions. Genomic DNA (10 ng) was amplified by PCR using AmpliTaq Gold (Applied Biosystems), denatured at 94°C for 5 min, and slowly re-annealed at room temperature for heteroduplex formation. Samples were then analyzed on the WAVE system, with the buffer gradient and oven temperature controlled by the 
VISTA Analysis
The VISTA genome sequence global alignment tools (21) identity in a 100-bp window.
Genotype Determination
Genotyping was carried out on a Pyrosequencer (PSQ96MA, Pyrosequencing Inc, Uppsala, Sweden) following the manufacturer's protocol. Genotyping quality control was achieved by, 1) PedCheck (23), to identify mis-inheritances among the family pedigrees; 2) Regenotyping of 12% total assays ; 3) complete LD among neighboring SNPs (-4944 and +224, -757 and +3679), and 4) Hardy-Weinberg equilibrium.
TagSNP Selection and Haplotype Estimation
In combination with the SNPs in current databases (SeattleSNP, dbSNP and Celera), there were 84 polymorphisms in the CRP gene, 21 of which were common (minor allele frequency [MAF] > 0.05) in Caucasians. To select the TagSNPs for further association analysis, we first genotyped these 21 SNPs in a subset of 96 individuals. We then used the EMLD software to analyze the pairwise correlations among these SNPs. TagSNP were selected by the criteria of complete linkage disequilibrium (LD) (r 2 =1). Haplotypes were estimated from the six SNPs using PHASE 2.0 (32, 33). There were five common haplotypes with frequencies of 5% or greater, resulting in 10 diplotypes with frequencies of 4% or higher.
Statistical Analysis
Phenotypic data were analyzed using generalized estimating equations with an exchangeable correlation matrix in a general linear model (GENMOD, SAS) (31) . Family number was considered as a random variable in the model so that the intra-class correlations could be used to adjust the standard error estimates for the familial dependencies among the subjects. Score statistics from GENMOD were tested by chi-square tests to test for the significance of the diplotypes or genotypes. Covariates included in each model were age, gender, field center, BMI, current smoker, and current alcohol intake. These covariates were selected because they were significantly associated with CRP in the majority of the regression models.
Either the diplotypes or individual SNP genotypes were the independent variables, and CRP and IMT were the dependent variables. CHD prevalence was tested for association with each SNP or the haplotype pairs by the same model but using a logit transformation of the dependent variable.
The diplotypes were tested as genotypes for association prior to individual SNP testing. Only the ten of the 15 diplotypes with frequencies of 4% or higher were analyzed, with the rarer diplotypes set to missing. For those dependent variables which showed significance in global diplotype tests (p<0.05), individual SNPs were tested using a two degree-of-freedom F test on the three genotype means to give indications of which SNP(s) may be responsible for the association. Prior to testing for the association of the SNP-757 with the dependent variables, those subjects with the C/C genotype were combined with the subjects who were C/T, as there were only 7 C/C subjects. Because of skewness, CRP was logarithmically transformed prior to the analysis.
RESULTS
Novel SNP Identification, TagSNP Selection and Haplotype Configuration
We identified 56 single nucleotide polymorphisms (SNPs) and 4 insertion/deletion polymorphisms in our experimental approach. Among these 60 polymorphisms, 20 SNPs have been previously reported in either public and private databases (dbSNP, Celera, NHLBI PGA SeattleSNP) or publications, the other 40 polymorphisms were novel. Pairwise correlations between SNPs were analyzed on genotype data from a subset of 96 unrelated individuals on 21 SNPs. We found that except for one SNP (+7598) that is located at the 3'-end of this region and was not in LD with any other SNPs, the other 20 SNPs belong to 4
complete-linkage-disequilibrium groups (r 2 =1) ( Table 2 ). Based on this result, we selected one The allele and estimated haplotype frequencies are shown in Table 3 . There are three very common haplotypes (0.354, 0.311 and 0.185), and two additional haplotype (0.074 and 0.062) with estimated frequency greater than 0.05.
Genotyping
Among the 8 SNPs that we genotyped in the entire sample set, SNP-4944 and +224 (in complete LD with -4944) were not in Hardy-Weinberg equilibrium (HWE) (p=0.024). All other SNPs were in Hardy-Weinberg equilibrium. Deviation from Hardy-Weinberg equilibrium is usually used as an accepted test for genotyping error. However, we have independently genotyped two SNPs (-4944 and +224) that are in complete LD (r 2 =1). In addition, the genotyping error was also monitored by mis-inheritances among the family pedigrees and regenotyping (0.17% error rate among 12% total re-genotyping samples). It is unlikely that genotyping error is the cause of the deviation of these two SNPs from Hardy-Weinberg equilibrium.
Association Analyses
P-values for the test of associa tion of the diplotypes with each of the study variables are shown in Table 4 . There was a trend towards significant association (p=0.045) of CRP diplotype with serum CRP (explained 1.4% of the CRP phenotypic variance), which prompted single-SNP analysis that followed. The highest CRP mean was 50% higher than the lowest diplotype mean (Table 5) . Approximately, 18% of the sample had the diplotypes with mean CRP over 3.0 mg/L.
CRP diplotype was not associated with IMT at any site or with CHD.
Because of the CRP diplotype results, individual SNPs were tested to see if one or more
SNPs explained the majority of the association signal (Table 6 ). SNP-757 (rs3093059) was highly associated with serum CRP. The additional separation of the -757 T allele into two alleles at the SNP-286 (rs3091244) locus seemed to further increase the association significance despite the increase in the degrees of freedom of the test. These associations remained significant at p<0.05 after Bonferonni adjustment for multiple testing of the six SNPs in the diplotype. The SNP-7180 (rs1341665) showed a borderline association (p=0.06) with serum CRP but was not borderline after multiple comparison adjustment.
There was a suggestion of an association of IMT of the common carotid artery (p=0.016)
for SNP-7180. However, after multiple comparison adjustment for these secondary hypothesis tests, the associations did not remain significant. None of CRP SNPs were associated with IMT of the internal carotid arteries or IMT at the bifurcations of the carotid arteries (data not shown).
The association of SNP-7180 was not associated with CHD prevalence (p=0.12).
Evolutionary Conservation by the VISTA Analysis
The VISTA analysis revealed 4 highly conserved regions within our SNP discovery target area (exc luding the CRP coding regions), 1) from the transcription starting point up to -300 bp; 2) at -7 kb in the 5'-flanking region; 3) at 2 kb downstream from the last CRP exon in the 3'-flanking region; and 4) 7-9 kb downstream from the last CRP exon and immediately upstream from the CRP pseudogene (Fig. 1) .
DISCUSSION
In this study, we used a complete SNP map on the CRP gene (7180 bp in the 5'-flanking region, exons, intron, and 7598 bp in the 3'-flanking region) to systematically investigate the associations between CRP genotypes, serum CRP level, and cardiovascular phenotypes. We found that CRP diplotypes and genotypes were associated with serum CRP levels in the NHLBI Family Heart Study (FHS) cohort. However, CRP genotypes were not associated with IMT or prevalence of coronary heart disease (CHD).
Several genetic polymorphisms on the CRP gene have been documented so far to be associated with CRP levels (5, 7, 17, 18, 28, 34, 35, 41) . These CRP polymorphisms included the (rs3093059), which represents a set of bi-allelic SNPs that are in complete LD with tri-allelic SNP-286, was added to the list of SNPs that are associated with serum CRP levels. We also confirmed the lack of association of SNP-717 (rs2794521) with serum CRP levels. The intronic SNP-62633 (rs1417938) and SNP+224 (rs1130864) were in complete LD in our cohort and were not significantly associated with serum CRP levels. These results demonstrated that serum CRP levels could be influenced by local genetic polymorphisms in the CRP gene.
The above SNPs were inconsistently associated with serum CRP levels in different studies. Besides spurious associations, one reason that may cause this discrepancy is the distinct LD patterns among different populations. It is postulated that the LD pattern is a function of the ethno-history of populations or subpopulations. It is likely that the TagSNPs used in association studies were not the functional SNPs; instead, they might be in LD, to a certain degree, with unidentified functional polymorphisms in their vicinity. Because the variation in CRP levels explained by the CRP gene is very small, the signal could be easily missed, especially in small samples of subjects, this could be one reason for the inconsistent findings among studies.
Our study did not provide direct evidence about which SNPs are the functional ones in regulation of the CRP expression. However, some suggestions were provided. The VISTA tool was built upon a widely accepted notion that the highly evolutionary conserved genomic regions among species are likely to be functionally important; and verse versa, functional constraints may have left footprints on nucleotide sequence by making some genomic regions evolve more slowly than average after species divergence. Therefore, the SNPs appearing on a highly conserved region are more likely to have a functional role. For example, SNP-7180 had borderline associations with serum CRP levels and IMT at the common carotid artery. Among the SNPs that are in complete LD with -7180, only -7180 and +7304 reside in highly conserved regions (Fig. 1) . In fact, an early transgenic study had shown that the 3'-flanking sequence of the CRP gene plays an important role in the CRP gene expression (38) . The SNP-286 is also in the highly conserved peak as revealed by the VISTA analysis. Recent functional analysis in cell culture suggested that this tri-allelic SNP is a functional one (7, 36) . It binds to the upstream stimulatory factor 1 (USF1) in vitro, and different alleles may have different binding affinities (7, 36) .
Intimal medial thickness of carotid arteries is a predictor of coronary artery disease. It has been previously reported that increased CRP levels were associated with the angiographicallydocumented coronary atherosclerotic disease in hypoalphalipoproteinemia patients (30) and the carotid IMT in elderly individuals (39) . In our study, CRP diplotype was not related to IMT of the common carotid artery. In a single-SNP analysis, the SNP-7180 showed an association with IMT at the common carotid artery which became nonsignificant after multiple testing adjustment. Previous reports showed that plasma CRP levels were associated with IMT at the common carotid artery (4, 6, 14, 16, 22, 29, 37) , but which were not associated after adjustment for age, BMI, visceral fat, and insulin (4, 13, 29, 37) . Given the small percentage of CRP variation explained by CRP genetic polymorphisms, one would not expect these polymorphisms to explain a significant proportion of IMT or CHD.
Conclusion
In this large cross-sectional family-based study using the NHLBI FHS (Family Heart Study) cohort, we found a significant impact of local SNPs of the CRP gene on plasma CRP levels, but we did not find direct evidence of genetically-controlled CRP elevations by local CRP SNPs contributing to cardiovascular phenotypes. Individuals' plasma CRP elevation may be a combined result from local genetic variants, polymorphisms on other genes, and environmental responses such as inflammation. Because CRP is significantly heritable, other genes than the structural CRP gene must help to regulate CRP levels. Therefore, further genetic characterization of CRP levels may be required to further investigate the role of CRP in cardiovascular disease. Cluster IV -717 +2447
Cluster V +7598 Table 3 . CRP allele and haplotype frequencies. Only the five haplotypes above were included in the analyses. There were 9 additional rare haplotypes, all with frequencies less than 0.5%. Nine degrees of freedom for each chi-square test on a general linear model score statistic. 
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